NCT06373016 Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder Status RECRUITING Phase NA
NCT06371352 Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression Status RECRUITING Phase NA
NCT06369805 EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION Status COMPLETED Phase N/A
NCT06369792 PROSPECTIVE EVALUATION OF BLOOD BIOMARKERS AS AN AID TO DIAGNOSTIC AND TREATMENT IN DRUG-NAIVE PATIENTS WITH DEPRESSION Status RECRUITING Phase N/A
NCT06365021 ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder Status RECRUITING Phase NA
NCT06363981 Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression Status RECRUITING Phase NA
NCT06336616 Getting Out of the House: Using Behavioral Activation to Increase Community Participation Status RECRUITING Phase NA
NCT06335875 Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones Status COMPLETED Phase NA
NCT06331286 The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity Status UNKNOWN Phase NA
NCT06328140 Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Status WITHDRAWN Phase N/A
NCT06315049 Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness Status COMPLETED Phase NA
NCT06282250 Seeing the Light: Early Intervention in People at Risk for Bipolar Disorder Status RECRUITING Phase NA
NCT06274567 Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder Status RECRUITING Phase NA
NCT06271304 Stabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder Status RECRUITING Phase NA
NCT06251908 REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention Status ACTIVE_NOT_RECRUITING Phase NA
NCT06235177 Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06229210 Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder Status RECRUITING Phase PHASE3